Veradermics, Incorporated

Healthcare · Biotechnology · United States

Last price 139.69 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.84B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDM...